Your browser version may not work well with NCBI's Web applications. More information here...

Recent Activity

Items 1 - 20 of 567
of 29Next
1:

Infiltrating lobular carcinoma of the breast: tumor characteristics and clinical outcome.

Arpino G, Bardou VJ, Clark GM, Elledge RM.

Breast Cancer Res. 2004;6(3):R149-56. Epub 2004 Feb 17.

PMID: 15084238 [PubMed - indexed for MEDLINE]

2:

Invasive lobular carcinoma of the breast: response to hormonal therapy and outcomes.

Rakha EA, El-Sayed ME, Powe DG, Green AR, Habashy H, Grainge MJ, Robertson JF, Blamey R, Gee J, Nicholson RI, Lee AH, Ellis IO.

Eur J Cancer. 2008 Jan;44(1):73-83. Epub 2007 Nov 26.

PMID: 18035533 [PubMed - indexed for MEDLINE]

3:

A comparison of cell cycle markers in well-differentiated lobular and ductal carcinomas.

Soslow RA, Carlson DL, Horenstein MG, Osborne MP.

Breast Cancer Res Treat. 2000 May;61(2):161-70.

PMID: 10942102 [PubMed - indexed for MEDLINE]

4:

Infiltrating lobular carcinoma of the breast. Clinicopathologic analysis of 975 cases with reference to data on conservative therapy and metastatic patterns.

Sastre-Garau X, Jouve M, Asselain B, Vincent-Salomon A, Beuzeboc P, Dorval T, Durand JC, Fourquet A, Pouillart P.

Cancer. 1996 Jan 1;77(1):113-20.

PMID: 8630916 [PubMed - indexed for MEDLINE]

5:

[Accuracy of conservative treatment for infiltrating lobular breast cancer: a retrospective study of 217 infiltrating lobular carcinomas and 2155 infiltrating ductal carcinomas]

Paumier A, Sagan C, Campion L, Fiche M, Andrieux N, Dravet F, Pioud R, Classe JM.

J Gynecol Obstet Biol Reprod (Paris). 2003 Oct;32(6):529-34. French.

PMID: 14593298 [PubMed - indexed for MEDLINE]

6:

Primary breast cancer phenotypes associated with propensity for central nervous system metastases.

Tham YL, Sexton K, Kramer R, Hilsenbeck S, Elledge R.

Cancer. 2006 Aug 15;107(4):696-704.

PMID: 16826579 [PubMed - indexed for MEDLINE]

7:

[Cytosolic pS2 levels and cellular proliferation in ER-positive and PgR-positive infiltrating ductal carcinomas of the breast]

Sánchez Salmón A, Argibay S, Arias JI, Ruibal A.

Rev Esp Med Nucl. 2005 May-Jun;24(3):185-90. Spanish.

PMID: 15847785 [PubMed - indexed for MEDLINE]

8:

Is invasive lobular carcinoma different from invasive ductal carcinoma?

Mersin H, Yildirim E, Gülben K, Berberoğlu U.

Eur J Surg Oncol. 2003 May;29(4):390-5.

PMID: 12711296 [PubMed - indexed for MEDLINE]

9:

Is survival from infiltrating lobular carcinoma of the breast different from that of infiltrating ductal carcinoma?

Jayasinghe UW, Bilous AM, Boyages J.

Breast J. 2007 Sep-Oct;13(5):479-85.

PMID: 17760669 [PubMed - indexed for MEDLINE]

10:

Different responses to preoperative chemotherapy for invasive lobular and invasive ductal breast carcinoma.

Cocquyt VF, Blondeel PN, Depypere HT, Praet MM, Schelfhout VR, Silva OE, Hurley J, Serreyn RF, Daems KK, Van Belle SJ.

Eur J Surg Oncol. 2003 May;29(4):361-7.

PMID: 12711290 [PubMed - indexed for MEDLINE]

11:

Distinct clinical and prognostic features of infiltrating lobular carcinoma of the breast: combined results of 15 International Breast Cancer Study Group clinical trials.

Pestalozzi BC, Zahrieh D, Mallon E, Gusterson BA, Price KN, Gelber RD, Holmberg SB, Lindtner J, Snyder R, Thürlimann B, Murray E, Viale G, Castiglione-Gertsch M, Coates AS, Goldhirsch A; International Breast Cancer Study Group.

J Clin Oncol. 2008 Jun 20;26(18):3006-14. Epub 2008 May 5.

PMID: 18458044 [PubMed - indexed for MEDLINE]

12:

HER2 as a prognostic factor in breast cancer.

Ménard S, Fortis S, Castiglioni F, Agresti R, Balsari A.

Oncology. 2001;61 Suppl 2:67-72. Review.

PMID: 11694790 [PubMed - indexed for MEDLINE]

13:

Invasive lobular carcinoma classic type: response to primary chemotherapy and survival outcomes.

Cristofanilli M, Gonzalez-Angulo A, Sneige N, Kau SW, Broglio K, Theriault RL, Valero V, Buzdar AU, Kuerer H, Buccholz TA, Hortobagyi GN.

J Clin Oncol. 2005 Jan 1;23(1):41-8.

PMID: 15625359 [PubMed - indexed for MEDLINE]

14:

Infiltrating lobular carcinoma. Is it different from infiltrating duct carcinoma?

Silverstein MJ, Lewinsky BS, Waisman JR, Gierson ED, Colburn WJ, Senofsky GM, Gamagami P.

Cancer. 1994 Mar 15;73(6):1673-7.

PMID: 8156495 [PubMed - indexed for MEDLINE]

15:

Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF.

Wenzel C, Bartsch R, Hussian D, Pluschnig U, Altorjai G, Zielinski CC, Lang A, Haid A, Jakesz R, Gnant M, Steger GG.

Breast Cancer Res Treat. 2007 Jul;104(1):109-14. Epub 2006 Oct 24.

PMID: 17061042 [PubMed - indexed for MEDLINE]

16:

Does routine grading of invasive lobular cancer of the breast have the same prognostic significance as for ductal cancers?

Sinha PS, Bendall S, Bates T.

Eur J Surg Oncol. 2000 Dec;26(8):733-7.

PMID: 11087636 [PubMed - indexed for MEDLINE]

17:

Outcomes of breast-conservation therapy for invasive lobular carcinoma are equivalent to those for invasive ductal carcinoma.

Vo TN, Meric-Bernstam F, Yi M, Buchholz TA, Ames FC, Kuerer HM, Bedrosian I, Hunt KK.

Am J Surg. 2006 Oct;192(4):552-5.

PMID: 16978974 [PubMed - indexed for MEDLINE]

19:

Invasive lobular carcinoma of the breast has better short- and long-term survival than invasive ductal carcinoma.

Toikkanen S, Pylkkänen L, Joensuu H.

Br J Cancer. 1997;76(9):1234-40.

PMID: 9365176 [PubMed - indexed for MEDLINE]

20:

Infiltrating lobular carcinoma--a comparison of diagnosis, management and outcome with infiltrating duct carcinoma.

Molland JG, Donnellan M, Janu NC, Carmalt HL, Kennedy CW, Gillett DJ.

Breast. 2004 Oct;13(5):389-96.

PMID: 15454194 [PubMed - indexed for MEDLINE]

Items 1 - 20 of 567
of 29Next